Abstract Number: 1403 • 2016 ACR/ARHP Annual Meeting
Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines
Background/Purpose: The ACR practice guidelines establish U.S. and international treatment recommendations. We sought to characterize the quality of the guidelines using the Appraisal of Guidelines…Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…Abstract Number: 1405 • 2016 ACR/ARHP Annual Meeting
Quality Measures in High Priority Rheumatologic Diseases: A Systematic Literature Review and Analysis
Background/Purpose: To identify published quality measures in rheumatoid arthritis (RA), osteoarthritis (OA), osteoporosis, spondyloarthropathy (SpA) and gout for the purpose of summarizing the existing measures…Abstract Number: 1406 • 2016 ACR/ARHP Annual Meeting
Towards Harmonized Data Collection in Rheumatoid Arthritis (RA): The EULAR Task Force for Standardizing a Minimum Data Collection for RA Observational Research
Background/Purpose: Collaborative research is compromised by heterogeneity of data collection in observational rheumatoid arthritis (RA) databases. Therefore a EULAR taskforce has been convened to develop…Abstract Number: 1407 • 2016 ACR/ARHP Annual Meeting
Disease Activity Trackers to Support Treat to Target Strategies: A Needs Assessment Survey
Background/Purpose: Custom-built software applications (apps) have become an integral part of medical practice today to help physicians be more efficient. They are being widely used…Abstract Number: 1408 • 2016 ACR/ARHP Annual Meeting
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Patient Reported Outcomes Among Patients with Rheumatoid Arthritis: Passion Study
Background/Purpose: Patient (pt) Support Program (PSP) is offered to pts who are prescribed adalimumab (ADA) for their Rheumatoid arthritis (RA). How participation in a PSP…Abstract Number: 1409 • 2016 ACR/ARHP Annual Meeting
Increase in the Use of Validated Disease Activity Scores in Current Daily Clinical Practice Compared to 2007
Background/Purpose: International guidelines and studies recommend rheumatologists to use validated measures to monitor disease activity, such as the Disease Activity Score of 28 joints (DAS28).…Abstract Number: 1410 • 2016 ACR/ARHP Annual Meeting
Is the Self-Assessment of Disease Activity (auto-DAS28) By Patients a Feasible and Acceptable Measure over the Long Term in Rheumatoid Arthritis (RA)? Three-Year Follow-up of a Nurse-Led Program in 771 Patients with Established RA
Background/Purpose: Patients with RA can be trained in self-assessment of disease activity by a self-assessment of their joints and calculation of the Disease activity Score…Abstract Number: 1411 • 2016 ACR/ARHP Annual Meeting
An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians
Background/Purpose: A major impediment to use of patient questionnaires in routine clinical care has been the absence of electronic entry for patients and for doctors…Abstract Number: 1412 • 2016 ACR/ARHP Annual Meeting
Validation of the Danish Version of the Stanford Health Assessment Questionnaire Disability Index and Determination of the Minimal Clinically Important Difference in a Cohort of Rheumatoid Arthritis Patients Using the Rasch Measurement Model
Background/Purpose: The Stanford Health Assessment Questionnaire Disability Index (HAQ-DI) is a widely used patient reported outcome for functional disability in RA. Minimal clinically important differences…Abstract Number: 1413 • 2016 ACR/ARHP Annual Meeting
Establishing Clinical Severity for Patient Reported Outcomes Measurement Information System Measures in Adult Patients with Rheumatic Diseases
Background/Purpose: Different patient reported outcome [PRO] measures are used for rheumatic diseases [RD], and there is lack of uniform generic illness measures across the disease…Abstract Number: 1414 • 2016 ACR/ARHP Annual Meeting
Access to an Active, Interactive Self-Assessment e-Health Platform Improves Patient-Physician Communication in Rheumatoid Arthritis: Results of a Randomized Controlled Trial Including 320 Patients over 1 Year
Background/Purpose: Electronic (e)-health is a rapidly evolving field. Interactive online services are available and may be useful for patients with chronic diseases such as rheumatoid…Abstract Number: 1415 • 2016 ACR/ARHP Annual Meeting
Impact of the Clinical Disease Activity Index to Treat to Target Rheumatoid Arthritis in the Ambulatory Setting
Background/Purpose: Since 2008 the Center for Medicare and Medicaid Services (CMS) has been in the process of changing patient care to quality-valued healthcare. In order…Abstract Number: 1416 • 2016 ACR/ARHP Annual Meeting
Sustained Improvement in Documentation of Disease Activity Measurement As a Quality Improvement Project at an Academic Rheumatology Clinic
Background/Purpose: Measurement of disease activity is considered a quality measure for management of rheumatoid arthritis (RA) patients. One validated measure of RA disease activity is…Abstract Number: 1417 • 2016 ACR/ARHP Annual Meeting
Back to Feeling Normal Again: Patients with Rheumatoid Arthritis in Remission
Background/Purpose: The American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) definition of remission in rheumatoid arthritis (RA) [1] lacks information on patient perceived remission [2].…
ACR Meeting Abstracts